Prophylaxis for acute gout flares after initiation of urate-lowering therapy

Role of Interleukin-1 Inhibitors in the Management of Gout

(2013) Tran H. Tran et al.   PHARMACOTHERAPY

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial

(2013) Essack Mitha et al.   RHEUMATOLOGY

Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator

(2013) Robert A Terkeltaub et al.   ARTHRITIS RESEARCH & THERAPY

Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial

(2012) Thomas H. Taylor et al.   AMERICAN JOURNAL OF MEDICINE

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

(2012) Naomi Schlesinger et al.   ANNALS OF THE RHEUMATIC DISEASES

Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study

(2012) Gianluca Trifirò et al.   ANNALS OF THE RHEUMATIC DISEASES

Purine-rich foods: an innocent bystander of gout attacks?

(2012) Pascal Richette et al.   ANNALS OF THE RHEUMATIC DISEASES

Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study

(2012) Frances Rees et al.   ANNALS OF THE RHEUMATIC DISEASES

Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

(2012) H. Ralph Schumacher et al.   ARTHRITIS AND RHEUMATISM

Gout and its comorbidities: implications for therapy

(2012) L. K. Stamp et al.   RHEUMATOLOGY

Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review

(2012) Rodolfo V. Curiel et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study

(2012) H. Ralph Schumacher et al.   ARTHRITIS CARE & RESEARCH

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

(2011) Robert T. Keenan et al.   AMERICAN JOURNAL OF MEDICINE

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

(2011) N. Schlesinger et al.   ANNALS OF THE RHEUMATIC DISEASES

Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors

(2011) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials

(2011) Robert L. Wortmann et al.   CLINICAL THERAPEUTICS

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

(2011)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

(2011) Patricia McGettigan et al.   PLOS MEDICINE

Hyperuricaemia and gout: state of the art and future perspectives

(2010) N. Dalbeth et al.   ANNALS OF THE RHEUMATIC DISEASES

Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis

(2010) Leo A. B. Joosten et al.   ARTHRITIS AND RHEUMATISM

Mechanisms of inflammation in gout

(2010) Nathalie Busso et al.   ARTHRITIS RESEARCH & THERAPY

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

(2010) Michael A Becker et al.   ARTHRITIS RESEARCH & THERAPY

Adherence with urate-lowering therapies for the treatment of gout

(2009) Leslie R Harrold et al.   ARTHRITIS RESEARCH & THERAPY

Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1  by mononuclear cells through a caspase 1-mediated process

(2008) E J Giamarellos-Bourboulis et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial

(2008) H. RALPH Schumacher et al.   ARTHRITIS AND RHEUMATISM

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

(2008) Hein JEM Janssens et al.   LANCET

Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy

(2008) Michael A. Becker et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Colchicine Update: 2008

(2008) Robert A. Terkeltaub   SEMINARS IN ARTHRITIS AND RHEUMATISM

Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation

(2008) George Nuki   Current Rheumatology Reports